Intuitive Surgical Shares Plunge as Da Vinci Procedure Growth Slows Sharply GLP-1 drugs and insurance uncertainty weigh on demand. "Da Vinci Robotic System." Credit: Intuitive Surgical Subscribe now Already have an account? Sign in.
